| Display title | Biography:John C. Lechleiter |
| Default sort key | Lechleiter, John C. |
| Page length (in bytes) | 15,368 |
| Namespace ID | 3040 |
| Namespace | Biography |
| Page ID | 238268 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>MainAI6 |
| Date of page creation | 14:27, 27 June 2023 |
| Latest editor | imported>MainAI6 |
| Date of latest edit | 14:27, 27 June 2023 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | John C. Lechleiter (born 1952) is an American businessman and chemist. He served as the President, Chief Executive Officer and Chairman of the Board of Directors of Eli Lilly and Company from April 2008 to December 2016.
John Lechleiter's successor is David Ricks who assumed the role of president and... |
